{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:48:55Z","timestamp":1782226135234,"version":"3.54.5"},"reference-count":20,"publisher":"Galenos Yayinevi","issue":"4","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk Gogus Kalp Dama"],"accepted":{"date-parts":[[2020,10,16]]},"published-print":{"date-parts":[[2021,10,20]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    This experimental study aims to investigate the pleurodesis effects of iodopovidone at different concentrations (2% and 4%) and sterile talc in a rat model.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Forty male Wistar Albino rats were randomly divided into four equal groups including 10 rats in each group. Groups 1, 2, and 3 were designed as the study, and Group 4 as the control group. In Group 1, 4 g sterile talc was given in the slurry form at 20 mL 0.9% saline solution, in Group 2 and Group 3 10% iodopovidone solution were given at 4% and 2% concentrations, respectively, and in Group 4, 0.9% saline was only administrated as 3 mL into the pleural space. All rats were sacrificed on Day 30 and evaluated for macroscopic and microscopic examination. Microscopic evaluation was performed for alveolar collapse, alveolar hemorrhage, alveolar infiltration and fibrosis. Brain, liver, and kidney tissues were also examined.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Iodopovidone macroscopically caused a significant adhesion similar to sterile talc at a concentration of 4%. The pleurodesis effect of iodopovidone at a concentration of 4% was significantly similar to talc, when microscopic parameters were evaluated. Granulomas due to sterile talc were observed in the opposite hemithorax. Brain, liver, and kidney examinations revealed no systemic distribution for both agents.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Iodopovidone is a powerful alternative to sterile talc with its easy accessibility and low cost. In this study, 4% iodopovidone was found to provide effective and safe pleurodesis in rats. We believe that the use of this concentration in clinical studies would provide more effective results.\n                  <\/jats:p>","DOI":"10.5606\/tgkdc.dergisi.2021.20664","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T16:21:32Z","timestamp":1643905292000},"page":"503-512","source":"Crossref","is-referenced-by-count":1,"title":["The comparison of pleurodesis effects of iodopovidone at different concentrations and magnesium silicate: An experimental study"],"prefix":"10.4274","volume":"29","author":[{"given":"Ekin","family":"Zorlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"K\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Pekcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesimi","family":"G\u00fcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koray","family":"Dural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkant","family":"\u00d6zpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"ref-1","unstructured":"Light RW. Pleural diseases. 3rd ed. Baltimore: Williams & Wilkins; 1995."},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004;(1):CD002916.","DOI":"10.1002\/14651858.CD002916.pub2"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Bethune N. Pleural poudrage: A new technic for the deliberate production of pleural adhesion as preliminary to lobectomy. The Journal of Thoracic Surgery 1934;4:251-61.","DOI":"10.1016\/S0096-5588(20)32384-9"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Almind M, Lange P, Viskum K. Spontaneous pneumothorax: Comparison of simple drainage, talc pleurodesis, and tetracycline pleurodesis. Thorax 1989;44:627-30.","DOI":"10.1136\/thx.44.8.627"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Steger V, Mika U, Toomes H, Walker T, Engel C, Kyriss T, et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg 2007;83:1940-5.","DOI":"10.1016\/j.athoracsur.2007.02.061"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Olivares-Torres CA, Laniado-Labor\u00edn R, Ch\u00e1vez-Garc\u00eda C, Le\u00f3n-Gastelum C, Reyes-Escamilla A, Light RW. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002;122:581-3.","DOI":"10.1378\/chest.122.2.581"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: Chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 2003;88:F531-3.","DOI":"10.1136\/fn.88.6.F531"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Efficacy and safety of iodopovidone in chemical pleurodesis: A meta-analysis of observational studies. Respir Med 2006;100:2043-7.","DOI":"10.1016\/j.rmed.2006.02.009"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S. Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest 1994;106:1241-5.","DOI":"10.1378\/chest.106.4.1241"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Vargas FS, Antonangelo L, Capelozzi V, Vaz MA, Genofre EH, Marchi E, et al. Lung damage in experimental pleurodesis induced by silver nitrate or talc: 1-year follow-up. Chest 2002;122:2122-6.","DOI":"10.1378\/chest.122.6.2122"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Arellano-Orden E, Romero-Falcon A, Juan JM, Oca\u00f1a Jurado M, Rodriguez-Panadero F, Montes-Worboys A. Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis. Respiration 2013;86:201-9.","DOI":"10.1159\/000342042"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Genofre EH, Marchi E, Vargas FS. Inflammation and clinical repercussions of pleurodesis induced by intrapleural talc administration. Clinics (Sao Paulo) 2007;62:627-34.","DOI":"10.1590\/S1807-59322007000500015"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest 1994;106:342-6.","DOI":"10.1378\/chest.106.2.342"},{"key":"ref-14","unstructured":"Echavarr\u00eda A, Pinz\u00f3n V, Bar\u00e9s JP, Fern\u00e1ndez E. Intracavitary treatment of malignant pleural effusion with iodine-povidone. Rev Med Panama 1991;16:69-74."},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Wagenfeld L, Zeitz O, Richard G. Visual loss after povidoneiodine pleurodesis. N Engl J Med 2007;357:1264-5.","DOI":"10.1056\/NEJMc070128"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Yazkan R, \u00d6zpolat B, Duman L, Bircan S, Bozkurt KK, G\u00fcne\u015f S. Identification of the concentration of iodopovidone pleurodesis in rats for the maximal effectiveness. Turk Gogus Kalp Dama 2013;21:737-42.","DOI":"10.5606\/tgkdc.dergisi.2013.7696"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"G\u00f6z\u00fcb\u00fcy\u00fck A, Ozpolat B, Ci\u00e7ek AF, Caylak H, Y\u00fccel O, Kavakl\u0131 K, et al. Comparison of side effects of oxytetracycline and talc pleurodesis: An experimental study. J Cardiothorac Surg 2010;5:128.","DOI":"10.1186\/1749-8090-5-128"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Andrade Neto JD, Terra RM, Teixeira RM, Pereira SV, Pego- Fernandes PM. Safety profile of the use of iodopovidone for pleurodesis in patients with malignant pleural effusion. Respiration 2015;90:369-75.","DOI":"10.1159\/000440727"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Yeginsu A, Karamustafaoglu A, Ozugurlu F, Etikan I. Iodopovidone pleurodesis does not effect thyroid function in normal adults. Interact Cardiovasc Thorac Surg 2007;6:563-4.","DOI":"10.1510\/icvts.2007.154914"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Fradkin JE, Wolff J. Iodide-induced thyrotoxicosis. Medicine (Baltimore) 1983;62:1-20.","DOI":"10.1097\/00005792-198301000-00001"}],"container-title":["Turkish Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:51:46Z","timestamp":1782222706000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjtcvs.org\/articles\/doi\/tgkdc.dergisi.2021.20664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10,20]]}},"URL":"https:\/\/doi.org\/10.5606\/tgkdc.dergisi.2021.20664","relation":{},"ISSN":["1301-5680","2149-8156"],"issn-type":[{"value":"1301-5680","type":"print"},{"value":"2149-8156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}